drugset / Trial / NCT04096027

Cabergoline Before or After Oocyte Collection for Follicular Resolution

NCT04096027

Phase 4 Completed 70 enrolled Fertility Center of Las Vegas
RandomizedParallel-groupSingle-blindTreatment

Summary

Randomized trial comparing the efficacy of two different times of administration of cabergoline in patients undergoing controlled ovarian stimulation and oocyte collection.

Timeline

Start
2019-09-23
Primary completion
2021-06-10
Completion
2021-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cabergoline Small molecule 0.5 mg Oral

Indications